‘Impacts Of New Paradigms On Skeletal Health Assessment: A Joint ISCD-IOF Meeting’

February 18, 2009 at 8:00 am Leave a comment


The International Osteoporosis Foundation (IOF) is pleased to announce ‘Impacts of New Paradigms on Skeletal Health Assessment: a joint ISCD-IOF meeting’ to take place in Orlando, FL, USA, March 11-14, 2009.





Prompt and concerted inter-organizational cooperation has yielded a four-day world-class skeletal health meeting with global representation and impact. At this joint meeting, IOF and the International Society for Clinical Densitometry (ISCD) anticipate an interchange of ideas that will stimulate thought and debate, with the goal of advancing global skeletal health.





The exciting scientific program will feature 6 educational symposia with presentations by several of the world’s leading researchers and clinicians in the field:

  • Osteoporosis in Men: How Far Have We Come, with presentations by
    Kenneth W. Lyles, MD, Nelson B. Watts, MD, CCD and Bonny Specker, PhD




  • State of the Art: Nutrition and Skeletal Health, with introduction by Peter Burckhardt MD, and presentations by René Rizzoli, MD, Bess Dawson-Hughes, MD and Bonny Specker, PhD




  • Non-Traditional Skeletal Assessment: Looking Outside the Box, with presentations by Kenneth Faulkner, PhD, Sharmila Majumdar, PhD and Mary Bouxsein, PhD




  • State of the Art: Exploring the Future of Skeletal Health, with presentations by Florent Elefteriou, PhD, Ego Seeman, MD, Mary L. Bouxsein, PhD




  • New Frontiers in Osteoporosis Therapies, with presentations by Robert Blank, MD, PhD, CCD, Stuart Silverman, MD, and John Bilezikian, MD




  • Pediatric Skeletal Health Symposum: 2007 Position Development Conference Review with presentations by Catherine Gordon, MD, Babette Zemel, PhD, Mary Leonard, MD, M. Zulf Mughal, MBChB and Linda DiMeglio.

Plenary presentations by Nelson B. Watts, MD, CCD and Jane Cauley, PhD will introduce the first of several stimulating international panel discussions on the WHO Fracture Risk Assessment Tool. The three different panel discussions include:

  • WHO 2008 Fracture Risk: Clinical Concerns and Controversies with the participation of John A. Kanis, MD, William Leslie, MD, CCD, Roman S. Lorenc, MD, PhD, CCD, Marjorie Luckey, MD, CCD, Sergio Ragi-Eis, MD, CCD, CDT, and Annie W. C. Kung, MD, CCD.




  • WHO 2008 Fracture Risk Worldwide Impacts on Osteoporosis Science with the participation of Kelly D. Krohn, MD, Theresa Kehoe, MD, René Rizzoli, MD and Michael R. McClung, MD.




  • WHO 2008 Fracture Risk: Reimbursement for Evaluation and Treatment , with participation by John Kanis, MD, and William Leslie, MD, CCD.

The extensive scientific program also features several Meet the Professor Sessions and Hands-on Workshops, abstract and poster presentations, a Position Development Conference Case Presentation and various concurrent clinically-focused sessions. For more detailed information about the scientific program, and about ACCME accreditation, please visit the ISCD website http://www.iscd.org.





Individual scientists will be honored at ISCD award ceremonies including the presentation of the IOF Medal Of Achievement. Additionally, there will be a Eulogy for IOF Founding President Pierre D. Delmas.





The IOF and ISCD hope to welcome you to Orlando and to what promises to be an outstanding scientific event.





—————————-

Article adapted by Medical News Today from original press release.

—————————-





Reminder: Registrants of the cancelled IOF World Congress on Osteoporosis in Bangkok (December 2008) who have submitted their abstracts to the ISCD-IOF meeting are entitled to take advantage of specially reduced registration rates. Visit the ISCD or IOF website for further details.




Source: Meeting Secretariat


International Osteoporosis Foundation

[Via http://www.medicalnewstoday.com]

Advertisements

Entry filed under: Uncategorized.

CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent Now Approved In The European Union For Treatment Of Patients With Diabetes Arthritis Drug Linked To Shingles Risk

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


Archives

Top Clicks

  • None

Blog Stats

  • 15,568 hits

%d bloggers like this: